- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 31/10 - Antimycotics
Patent holdings for IPC class A61P 31/10
Total number of patents in this class: 2823
10-year publication summary
|
61
|
68
|
128
|
180
|
164
|
191
|
167
|
195
|
361
|
163
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| King Faisal University | 921 |
206 |
| Nihon Nohyaku Co., Ltd. | 330 |
26 |
| Scynexis, Inc. | 67 |
25 |
| Centre National de La Recherche Scientifique | 10635 |
20 |
| POLA Pharma Inc. | 77 |
20 |
| BASF SE | 21080 |
19 |
| The Board of Trustees of the University of Illinois | 2713 |
19 |
| Shanghai Techwell Biopharmaceutical Co., Ltd. | 65 |
16 |
| Eisai R&D Management Co., Ltd. | 1210 |
15 |
| F2g Ltd | 49 |
14 |
| Kaken Pharmaceutical Co., Ltd. | 105 |
13 |
| Institut National de La Sante et de La Recherche Medicale (inserm) | 2953 |
12 |
| University of Georgia Research Foundation, Inc. | 1045 |
11 |
| Janssen Pharmaceutica N.V. | 3349 |
10 |
| Board of Regents, The University of Texas System | 5917 |
10 |
| The Brigham and Women's Hospital, Inc. | 2218 |
10 |
| Amtixbio Co., Ltd. | 40 |
10 |
| The Regents of the University of California | 20230 |
9 |
| The Research Foundation for The State University of New York | 1654 |
9 |
| Gedea Biotech AB | 16 |
9 |
| Other owners | 2340 |